Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Daré Bioscience Launch Phase One Of Patient-Focused Campaign With Rosy Wellness To Support DARE To PLAY Sildenafil Cream

Author: Benzinga Newsdesk | July 29, 2025 08:05am

A first-of-its-kind solution for women's arousal in a proprietary topical formulation demonstrated to work where women need it most

Targeted to be available by prescription in the fourth quarter of 2025

Collaboration leverages Rosy Wellness' extensive reach and community of over 250,000 women; campaign designed to drive awareness and support women with arousal concerns

Posted In: DARE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist